Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Senior Vice President | March 13, 2009 | March 16, 2009 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date March 13, 2009 · Filed March 16, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 27,354 |
Reported balance
After 2009-03-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2009-03-13 · Grant · Acquired 951 · Balance 27,354 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ChemoCentryx, Inc.
Report date October 20, 2022 · Filed October 24, 2022
Section 16 reporting ended · disclosed 2022-10-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 1
1 source rowRow 1 · 2022-10-20 · Disposition to issuer · Disposed 148,127 · Balance 0 F1: Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 3, 2022, among Amgen Inc. ("Parent"), Carnation Merger Sub, Inc. ("Merger Sub") and ChemoCentryx, Inc. (the "Company"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Shares," and each such share, a "Share") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised, F2: (Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the "Merger Consideration"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $22.39 | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-10-20 · Disposition to issuer · Disposed 8,342 · Balance 0 F3: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.06 | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-10-20 · Disposition to issuer · Disposed 4,504 · Balance 0 F3: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $11.60 | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-10-20 · Disposition to issuer · Disposed 12,287 · Balance 0 F3: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.94 | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-10-20 · Disposition to issuer · Disposed 13,352 · Balance 0 F3: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.94 | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-10-20 · Disposition to issuer · Disposed 12,500 · Balance 0 F3: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-10-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-10-20 · Disposition to issuer · Disposed 15,723 · Balance 0 F4: At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 3, 2022, among Amgen Inc. ("Parent"), Carnation Merger Sub, Inc. ("Merger Sub") and ChemoCentryx, Inc. (the "Company"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Shares," and each such share, a "Share") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,
F2: (Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the "Merger Consideration"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares.
F3: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.
F4: At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 52 | $23.53 | $1,223.56 |
DisclosureSEC source: 0000078003-06-000140 · fec1225.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,915 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:10 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 67 | $23.66 | $1,585.22 |
DisclosureSEC source: 0000078003-06-000129 · fec1217.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,863 Underlying: Common Stock · 67 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:33 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 222 | $24.89 | $5,525.58 |
DisclosureSEC source: 0000078003-06-000118 · fec1208.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,796 Underlying: Common Stock · 222 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 14 | $25.33 | $354.62 |
DisclosureSEC source: 0000078003-06-000103 · fec1199.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,574 Underlying: Common Stock · 14 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 21, 2006 Filed Apr 24, 2006 16:16 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,600 | $0.00 Strike: $12.42 | $0.00 |
DisclosureSEC source: 0000078003-06-000084 · fec1183.xml · derivative · entry 7 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,600 shares Expires 2006-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 22,1997. Read SEC document |
| April 21, 2006 Filed Apr 24, 2006 16:16 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 33,600 | $25.07 | $842,352.00 |
DisclosureSEC source: 0000078003-06-000084 · fec1183.xml · nonDerivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,310 Read SEC document |
| April 21, 2006 Filed Apr 24, 2006 16:16 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 33,600 | $12.42 | $417,312.00 |
DisclosureSEC source: 0000078003-06-000084 · fec1183.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2006 Filed Apr 10, 2006 16:49 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 29 | $26.05 | $755.45 |
DisclosureSEC source: 0000078003-06-000067 · fec1170.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,123 Read SEC document |
| March 15, 2006 Filed Mar 17, 2006 16:56 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 927 | $25.95 | $24,055.65 |
DisclosureSEC source: 0000078003-06-000049 · fec1149.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,561 Underlying: Common Stock · 927 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| February 27, 2006 Filed Mar 1, 2006 16:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,206 | $26.55 | $58,569.30 |
DisclosureSEC source: 0000078003-06-000040 · fec1140.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,092 Read SEC document |
| February 24, 2006 Filed Feb 28, 2006 16:57 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 238 | $26.28 | $6,254.64 |
DisclosureSEC source: 0000078003-06-000038 · fec1138.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,124 F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| February 23, 2006 Filed Feb 24, 2006 22:35 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 152,000 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0000078003-06-000031 · fec1131.xml · derivative · entry 7 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,000 Underlying: Common Stock · 152,000 shares Expires 2016-02-22 Read SEC document |
| February 23, 2006 Filed Feb 24, 2006 22:35 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 41,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000031 · fec1131.xml · nonDerivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,298 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 23, 2006 Filed Feb 24, 2006 22:35 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 12,260 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000031 · fec1131.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,508 F1 · shares: The reported transaction constitutes the grant of Restricted Stock Units. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 18:43 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,052 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000078003-06-000027 · fec1109.xml · derivative · entry 10 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 2,052 shares Expires 2007-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 28,1998. F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 18:43 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,268 | $0.00 Strike: $12.42 | $0.00 |
DisclosureSEC source: 0000078003-06-000027 · fec1109.xml · derivative · entry 9 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 2,268 shares Expires 2006-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 22,1997. F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 18:43 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 2,052 | $25.27 | $51,854.04 |
DisclosureSEC source: 0000078003-06-000027 · fec1109.xml · nonDerivative · entry 4 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,339 F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 18:43 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 2,052 | $18.35 | $37,654.20 |
DisclosureSEC source: 0000078003-06-000027 · fec1109.xml · nonDerivative · entry 3 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 18:43 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 2,268 | $25.27 | $57,312.36 |
DisclosureSEC source: 0000078003-06-000027 · fec1109.xml · nonDerivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,339 F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 18:43 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 2,268 | $12.42 | $28,168.56 |
DisclosureSEC source: 0000078003-06-000027 · fec1109.xml · nonDerivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| December 30, 2005 Filed Jan 4, 2006 18:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 19 | $23.32 | $443.08 |
DisclosureSEC source: 0000078003-06-000006 · fec1099.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 598 Underlying: Common Stock · 19 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| December 30, 2005 Filed Jan 4, 2006 18:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 49 | $23.32 | $1,142.68 |
DisclosureSEC source: 0000078003-06-000006 · fec1099.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,491 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2005 Filed Dec 19, 2005 17:37 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 19 | $22.79 | $433.01 |
DisclosureSEC source: 0000078003-05-000304 · fec1087.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 579 Underlying: Common Stock · 19 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| December 15, 2005 Filed Dec 19, 2005 17:37 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 49 | $22.79 | $1,116.71 |
DisclosureSEC source: 0000078003-05-000304 · fec1087.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,442 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 30, 2005 Filed Dec 1, 2005 20:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 21 | $21.20 Strike: $0.00 | $445.20 |
DisclosureSEC source: 0000078003-05-000290 · fec1077.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 560 Underlying: Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| November 30, 2005 Filed Dec 1, 2005 20:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 68 | $21.20 Strike: $0.00 | $1,441.60 |
DisclosureSEC source: 0000078003-05-000290 · fec1077.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,393 Underlying: Common Stock · 68 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 15, 2005 Filed Nov 17, 2005 17:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 24 | $21.89 Strike: $0.00 | $525.36 |
DisclosureSEC source: 0000078003-05-000281 · fec1068.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 539 Underlying: Common Stock · 24 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| November 15, 2005 Filed Nov 17, 2005 17:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 197 | $21.89 Strike: $0.00 | $4,312.33 |
DisclosureSEC source: 0000078003-05-000281 · fec1068.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,325 Underlying: Common Stock · 197 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 01, 2005 Filed Nov 2, 2005 21:51 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 20 | $21.55 Strike: $0.00 | $431.00 |
DisclosureSEC source: 0000078003-05-000264 · fec1057.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 515 Underlying: Common Stock · 20 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| November 01, 2005 Filed Nov 2, 2005 21:51 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 67 | $21.55 Strike: $0.00 | $1,443.85 |
DisclosureSEC source: 0000078003-05-000264 · fec1057.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,128 Underlying: Common Stock · 67 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 14, 2005 Filed Oct 18, 2005 19:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 18 | $24.32 Strike: $0.00 | $437.76 |
DisclosureSEC source: 0000078003-05-000254 · fec1047.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 495 Underlying: Common Stock · 18 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| October 14, 2005 Filed Oct 18, 2005 19:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 51 | $24.32 Strike: $0.00 | $1,240.32 |
DisclosureSEC source: 0000078003-05-000254 · fec1047.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,061 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2005 Filed Oct 3, 2005 21:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 18 | $24.97 Strike: $0.00 | $449.46 |
DisclosureSEC source: 0000078003-05-000242 · fec1035.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 477 Underlying: Common Stock · 18 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| September 30, 2005 Filed Oct 3, 2005 21:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 52 | $24.97 Strike: $0.00 | $1,298.44 |
DisclosureSEC source: 0000078003-05-000242 · fec1035.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,010 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2005 Filed Sep 16, 2005 15:20 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 17 | $25.70 Strike: $0.00 | $436.90 |
DisclosureSEC source: 0000078003-05-000234 · fec1027.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 459 Underlying: Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| September 15, 2005 Filed Sep 16, 2005 15:20 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 49 | $25.70 Strike: $0.00 | $1,259.30 |
DisclosureSEC source: 0000078003-05-000234 · fec1027.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,958 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 31, 2005 Filed Sep 2, 2005 15:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 17 | $25.47 Strike: $0.00 | $432.99 |
DisclosureSEC source: 0000078003-05-000225 · fec1016.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 442 Underlying: Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| August 31, 2005 Filed Sep 2, 2005 15:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 54 | $25.47 Strike: $0.00 | $1,375.38 |
DisclosureSEC source: 0000078003-05-000225 · fec1016.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,909 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2005 Filed Aug 16, 2005 20:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 15 | $26.20 Strike: $0.00 | $393.00 |
DisclosureSEC source: 0000078003-05-000216 · fec1007.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 425 Underlying: Common Stock · 15 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| August 15, 2005 Filed Aug 16, 2005 20:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 162 | $26.20 Strike: $0.00 | $4,244.40 |
DisclosureSEC source: 0000078003-05-000216 · fec1007.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,855 Underlying: Common Stock · 162 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 29, 2005 Filed Aug 1, 2005 19:55 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 51 | $26.50 Strike: $0.00 | $1,351.50 |
DisclosureSEC source: 0000078003-05-000207 · fec999.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,693 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 15, 2005 Filed Jul 19, 2005 13:51 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 49 | $27.57 Strike: $0.00 | $1,350.93 |
DisclosureSEC source: 0000078003-05-000191 · fec991.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,642 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 18:57 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 48 | $27.58 Strike: $0.00 | $1,323.84 |
DisclosureSEC source: 0000078003-05-000184 · fec978.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,593 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 15, 2005 Filed Jun 17, 2005 12:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 43 | $28.43 Strike: $0.00 | $1,222.49 |
DisclosureSEC source: 0000078003-05-000153 · fec970.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,545 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 31, 2005 Filed Jun 1, 2005 17:33 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 47 | $27.90 Strike: $0.00 | $1,311.30 |
DisclosureSEC source: 0000078003-05-000141 · fec962.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,502 Underlying: Common Stock · 47 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 13, 2005 Filed May 16, 2005 17:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 147 | $27.86 Strike: $0.00 | $4,095.42 |
DisclosureSEC source: 0000078003-05-000132 · fec953.xml · derivative · entry 2 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,455 Underlying: Common Stock · 147 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 13, 2005 Filed May 16, 2005 17:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 3 | $27.86 Strike: $0.00 | $83.58 |
DisclosureSEC source: 0000078003-05-000132 · fec953.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 410 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · ownership.nature: I hereby disclaim beneficial ownership of all shares held by members of my family. Read SEC document |
| April 29, 2005 Filed May 3, 2005 18:56 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 49 | $27.17 Strike: $0.00 | $1,331.33 |
DisclosureSEC source: 0000078003-05-000115 · fec947.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,308 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 11, 2005 Filed Mar 15, 2005 16:36 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 895 | $26.36 Strike: $0.00 | $23,592.20 |
DisclosureSEC source: 0000078003-05-000070 · fec893.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,263 Underlying: Common Stock · 895 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.